Effects of systemic administration of oxytocin on contextual fear extinction in a rat model of post-traumatic stress disorder

Basic and Clinical Neuroscience

Volumn 4, Issue 4, 2013, Pages 37-44

  Eskandarian, Sharaf ^a,b   Vafaei, AbbasAli ^a   Vaezi, Gholam Hassan ^b   Taherian, Fatemeh ^a   Kashefi, Adel ^a   Rashidy Pour, Ali ^a  

^a SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Fear conditioning; Fear extinction; Oxytocin; Ptsd

Indexed keywords

OXYTOCIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC STRESS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG TREATMENT FAILURE; FEAR; FORCED SWIM TEST; LEARNING DISORDER; MALE; MEMORY DISORDER; MOTOR ACTIVITY; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; RAT; REINFORCEMENT; TREATMENT OUTCOME;

EID: 84890069525     PISSN: 2008126X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Abrari, K., Rashidy-Pour, A., Semnanian, S. & Fathollahi, Y. (2008) Administration of corticosterone after memory reactivation disrupts subsequent retrieval of a contextual conditioned fear memory: Dependence upon training intensity. Neurobiology of Learning and Memory 89, 178-184.
2. Agorastos, A., Marmar, C. R. & Otte, C. (2011) Immediate and early behavioral interventions for the prevention of acute and posttraumatic stress disorder. Current Opinion in Psychiatry 24, 526-532.
3. Barrett, D. & Gonzalez-Lima, F. (2004) Behavioral effects of metyrapone on Pavlovian extinction. Neuroscience Letters 371, 91-96.
4. Bosch, O. J., Meddle, S. L., Beiderbeck, D. I., Douglas, A. J. & Neumann, I. D. (2005) Brain oxytocin correlates with maternal aggression: Link to anxiety. The Journal of Neuroscience 25, 6807-6815.
5. Charney, D. S., Deutch, A. Y., Krystal, J. H., Southwick, S. M. & Davis, M. (1993) Psychobiologic mechanisms of posttraumatic stress disorder. Archives of General Psychiatry 50, 294.
6. Cloitre, M. (2009) Effective psychotherapies for posttraumatic stress disorder: A review and critique. CNS Spectr 14(1 Suppl 1), 32-43.
7. Davis, M., Ressler, K., Rothbaum, B. O. & Richardson, R. (2006) Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biological Psychiatry 60, 369-375.
8. Devilly, G. J. & Huther, A. (2008) Perceived distress and endorsement for cognitive-or exposure-based treatments following trauma. Australian Psychologist 43, 7-14.
9. Dunlop, B.W, Mansson, E. & Gerardi, M. (2012) Pharmacological Innovations for Posttraumatic Stress Disorder and Medication-Enhanced Psychotherapy. Current Pharmaceutical Design 18, 5645-5658.
10. Engelmann, M., Wotjak, C.T., Neumann, I., Ludwig, M. & Landgraf, R. (1996) Behavioral consequences of intracerebral vasopressin and oxytocin: Focus on learning and memory. Neuroscience and Biobehavioral Review 20,341-58.
11. Gimpl, G. & Fahrenholz, F. (2001) The oxytocin receptor system: Structure, function, and regulation. Physiological Reviews 81, 629-683.
12. Heinrichs, M. & Domes, G. (2008) Neuropeptides and social behaviour: Effects of oxytocin and vasopressin in humans. Progress in Brain Research 170, 337-350.
13. Ivell, R., Balvers, M., Rust, W., Bathgate, R. & Einspanier, A. (1997) Oxytocin and male reproductive function. In: The Fate of the Male Germ Cell, ed.^eds. Springer.
14. Iwamoto, Y., Morinobu, S., Takahashi, T. & Yamawaki, S. (2007) Single prolonged stress increases contextual freezing and the expression of glycine transporter 1 and vesicle-associated membrane protein 2 mRNA in the hippocampus of rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31, 642-651.
15. Jin, X. C., Lu, Y. F., Yang, X. F., Ma, L. & Li, B. M. (2007) Glucocorticoid receptors in the basolateral nucleus of amygdala are required for postreactivation reconsolidation of auditory fear memory. European Journal of Neuroscience 25, 3702-3712.
16. Keverne, E. B. & Curley, J. P. (2004) Vasopressin, oxytocin and social behaviour. Current Opinion in Neurobiology 14, 777- 783.
17. Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B. & Meyer-Lindenberg, A. (2005) Oxytocin modulates neural circuitry for social cognition and fear in humans. The Journal of neuroscience 25, 11489-11493.
18. Kohda, K., Harada, K., Kato, K., Hoshino, A., Motohashi, J., Yamaji, T., Morinobu, S., Matsuoka, N. & Kato, N. (2007) Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: A putative post-traumatic stress disorder model. Neuroscience 148, 22-33.
19. Kovács, G. L., Vécsei, L. & Telegdy, G. (1978) Opposite action of oxytocin to vasopressin in passive avoidance behavior in rats. Physiology & Behavior 20, 801-802.
20. Labuschagne, I., Phan, K. L., Wood, A., Angstadt, M., Chua, P., Heinrichs, M., Stout, J. C. & Nathan, P. J. (2010) Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology 35, 2403-2413.
21. LeDoux, J. E., Iwata, J., Cicchetti, P. & Reis, D. (1988) Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. The Journal of Neuroscience 8, 2517-2529.
22. Liberzon, I., Krstov, M. & Young, E. A. (1997) Stress-restress: effects on ACTH and fast feedback. Psychoneuroendocrinology 22, 443-453.
23. Missig, G., Ayers, L. W., Schulkin, J. & Rosen, J. B. (2010) Oxytocin reduces background anxiety in a fear-potentiated startle paradigm. Neuropsychopharmacology 35, 2607-2616.
24. Neumann, I. (2008) Brain oxytocin: A key regulator of emotional and social behaviours in both females and males. Journal of Neuroendocrinology 20, 858-865.
25. Neumann, I., Wigger, A., Torner, L., Holsboer, F. & Landgraf, R. (2000) Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: Partial action within the paraventricular nucleus. Journal of Neuroendocrinology 12, 235-244.
26. Neumann, I. D. (2002) Involvement of the brain oxytocin system in stress coping: Interactions with the hypothalamo-pituitary-adrenal axis. Progress in Brain Research 139, 147-162.
27. Olatunji, B. O., Cisler, J. M. & Deacon, B. J. (2010) Efficacy of cognitive behavioral therapy for anxiety disorders: A review of meta-analytic findings. Psychiatric Clinics of North America 33, 557.
28. Olff, M., Langeland, W., Witteveen, A. & Denys, D. (2010) A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder. CNS Spectr 15, 522-530.
29. Pedersen, C. A., Ascher, J. A., Monroe, Y. L. & Prange, A. J. (1982) Oxytocin induces maternal behavior in virgin female rats. Science 216, 648-650.
30. Petersson, M., Hulting, A.L. & Uvnäs-Moberg, K. (1999) Oxytocin causes a sustained decrease in plasma levels of corticosterone in rats. Neuroscience letters 264, 41-44.
31. Phillips, R. & LeDoux, J. (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behavioural Neuroscencei 106, 274-285.
32. Pitman, R. K. (1997) Overview of biological themes in PTSD. Annals of the New York Academy of Sciences 821, 1-9.
33. Rashidy-Pour, A., Sadeghi, H., Taherain, A.A., Vafaei, A.A. & Fathollahi Y (2004) The effects of acute restraint stress and dexamethasone on retrieval of long-term memory in rats: an interaction with opiate system. Behavioral Brain Research. 154,193-8.
34. Rauch, S. L., Whalen, P. J., Shin, L. M., McInerney, S. C., Macklin, M. L., Lasko, N. B., Orr, S. P. & Pitman, R. K. (2000) Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biological Psychiatry 47, 769-776.
35. Roberts, N., Kitchiner, N., Kenardy, J. & Bisson, J. (2009) Multiple session early psychological interventions for the prevention of post-traumatic stress disorder. Cochrane Database of Systematic Reviews 3.
36. Rothbaum, B. O. & Davis, M. (2003) Applying learning principles to the treatment of Post-Trauma reactions. Annals of the New York Academy of Sciences 1008, 112-121.
37. Shin, L. M., Rauch, S. L. & Pitman, R. K. (2006) Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Annals of the New York Academy of Sciences 1071, 67-79.
38. Toth I, Neumann ID, & Slattery DA(2012) Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner. Psychopharmacology (Berl). 223,149-58.
39. Vaccari, C., Lolait, S. J. & Ostrowski, N. L. (1998) Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology 139, 5015- 5033.
40. Viviani, D., Charlet, A., van den Burg, E., Robinet, C., Hurni, N., Abatis, M., Magara, F. & Stoop, R. (2011) Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science Signaling 333, 104.
41. Wiersma, A., Sluyter, S. & Driscoll, P. (1992) Opposite effects of central amygdaloid vasopressin and oxytocin on the regulation of conditioned stress responses in male rats. Oxytocin in Maternal, Sexual, and Social Behaviors 460.
42. Yamamoto, S., Morinobu, S., Fuchikami, M., Kurata, A., Kozuru, T. & Yamawaki, S. (2007) Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD. Neuropsychopharmacology 33, 2108-2116.
43. Yamamoto, S., Morinobu, S., Takei, S., Fuchikami, M., Matsuki, A., Yamawaki, S. & Liberzon, I. (2009) Single prolonged stress: toward an animal model of posttraumatic stress disorder. Depression and Anxiety 26, 1110-1117.
44. Yang, Y.L., Chao, P.K. & Lu, K.T. (2005) Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear. Neuropsychopharmacology 31, 912-924.
45. Yang, Y.L., Chao, P.K., Ro, L.S., Wo, Y.Y. P. & Lu, K.T. (2006) Glutamate NMDA receptors within the amygdala participate in the modulatory effect of glucocorticoids on extinction of conditioned fear in rats. Neuropsychopharmacology 32, 1042-1051.
46. Zaidi, S,M. & Heller, H. (1974) Can neurohypophysial hormones cross the blood-cerebrospinal fluid barrier? J Endocrinol. 60,195-6.